Will India's Covishield export halt amid coronavirus surge hurt its vaccine diplomacy? | South China Morning Post

Officials have defended the decision to 'calibrate' Oxford/AstraZeneca vaccine exports made by the Serum Institute of India as the country experiences a second wave But while production is being ramped up, the temporary halt in deliveries could affect Prime Minister Narendra Modi's soft power efforts India says it is "calibrating" its vaccine exports in an attempt to curb a spike in Covid-19 cases, raising doubts about whether it can maintain its balancing act in meeting local and international vaccine demand. As countries anxiously await delayed shipments of Covid-19 vaccines, India has defended its decision to halt exports of Covishield, the…